118 related articles for article (PubMed ID: 26987743)
1. Current Findings and Mechanisms of Action of Disulfiram in the Treatment of Alcohol Dependence.
Mutschler J; Grosshans M; Soyka M; Rösner S
Pharmacopsychiatry; 2016 Jul; 49(4):137-41. PubMed ID: 26987743
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome.
Bernier M; Harney D; Koay YC; Diaz A; Singh A; Wahl D; Pulpitel T; Ali A; Guiterrez V; Mitchell SJ; Kim EY; Mach J; Price NL; Aon MA; LeCouteur DG; Cogger VC; Fernandez-Hernando C; O'Sullivan J; Larance M; Cuervo AM; de Cabo R
NPJ Aging Mech Dis; 2020; 6():8. PubMed ID: 32714562
[TBL] [Abstract][Full Text] [Related]
3. DISCUSSION ON THE VALUE OF ALCOHOL AS A THERAPEUTIC AGENT.
Proc R Soc Med; 1920; 13(Ther Pharmacol Sect):56. PubMed ID: 19981517
[No Abstract] [Full Text] [Related]
4. Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents.
Ekinci E; Rohondia S; Khan R; Dou QP
Recent Pat Anticancer Drug Discov; 2019; 14(2):113-132. PubMed ID: 31084595
[TBL] [Abstract][Full Text] [Related]
5. Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.
Goh ET; Morgan MY
Aliment Pharmacol Ther; 2017 Apr; 45(7):865-882. PubMed ID: 28220511
[TBL] [Abstract][Full Text] [Related]
6. Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.
Sinclair JM; Chambers SE; Shiles CJ; Baldwin DS
Drug Saf; 2016 Jul; 39(7):627-45. PubMed ID: 27023898
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
9. ALCOHOL DEPENDENCE--NEUROBIOLOGY AND TREATMENT.
Michalak A; Biała G
Acta Pol Pharm; 2016; 73(1):3-12. PubMed ID: 27008795
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
Grant JE; Potenza MN; Kraus SW; Petrakis IL
J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone: A Pan-Addiction Treatment?
Aboujaoude E; Salame WO
CNS Drugs; 2016 Aug; 30(8):719-33. PubMed ID: 27401883
[TBL] [Abstract][Full Text] [Related]
12. Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON).
Malone M; McDonald R; Vittitow A; Chen J; Obi R; Schatz D; Tofighi B; Garment A; Kermack A; Goldfeld K; Gold H; Laska E; Rotrosen J; Lee JD
Contemp Clin Trials; 2019 Jun; 81():102-109. PubMed ID: 30986535
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.
Viola-Rhenals M; Patel KR; Jaimes-Santamaria L; Wu G; Liu J; Dou QP
Curr Med Chem; 2018 Feb; 25(4):506-524. PubMed ID: 29065820
[TBL] [Abstract][Full Text] [Related]
14. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
Kelly JF; Humphreys K; Ferri M
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
[TBL] [Abstract][Full Text] [Related]
15. Overview of Gilbert's syndrome.
King D; Armstrong MJ
Drug Ther Bull; 2019 Feb; 57(2):27-31. PubMed ID: 30709860
[No Abstract] [Full Text] [Related]
16. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder.
Reus VI; Fochtmann LJ; Bukstein O; Eyler AE; Hilty DM; Horvitz-Lennon M; Mahoney J; Pasic J; Weaver M; Wills CD; McIntyre J; Kidd J; Yager J; Hong SH
Am J Psychiatry; 2018 Jan; 175(1):86-90. PubMed ID: 29301420
[No Abstract] [Full Text] [Related]
17. Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
Ragia G; Manolopoulos VG
Curr Pharm Biotechnol; 2017; 18(3):221-230. PubMed ID: 28240173
[TBL] [Abstract][Full Text] [Related]
18. Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.
Hendershot CS; Wardell JD; Samokhvalov AV; Rehm J
Addict Biol; 2017 Nov; 22(6):1515-1527. PubMed ID: 27411969
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
